Michael Khouw is a 20 year veteran of the financial services industry with broad experience as a strategist, analyst, portfolio manager and proprietary trader of equities, commodities and equity and index derivatives for both buy-side and sell-side firms.
Mike is the co-author of "Trade Options, Make Money" a comprehensive guide to understanding the value of options, optionality, volatility and strategy for both retail and institutional investors that includes practical real-life examples of do's and don'ts for everyone from options novices to seasoned practitioners.
Mike was previously a partner at Cantor Fitzgerald and a principal and managing director at CRT Capital. Mike also held senior trader positions at Bluefin Trading, LLC and Gateway Partners, LLC, both Proprietary Trading Firms based in New York, and as an analyst at Ivory Capital, a research-intensive, fundamental value-based investment firm headquartered in Los Angeles.
In his current role Mike advises hedge funds, mutual funds, insurance companies, family offices and pension plans in the effective use of listed options for enhancing returns and managing risk.
In addition, Mike shares his insights through articles as a contributor for thestreet.com, and through frequent speaking engagements at conferences on a broad array of topics including trading strategy at investment conferences such as InvesTools, The Money Show, and Inside ETFs, on market structure and regulation at the Futures Industry Association Conference and the Options Industry Conference, and on careers in finance as a keynote speaker at the Drexel University, Lebow School of Business.
Mike is a Former Member of the Philadelphia Stock Exchange Nasdaq/OMX, NYSE-AMEX, and the New York Mercantile Exchange. Mike holds a B.A. from Tufts University.
Follow Michael Khouw on Twitter @Michael_Khouw.
CNBC Contributor Mike Khouw highlights a flurry of bullish options activity in Abercrombie and Fitch.
As if Twitter's stock didn't have enough problems, it now faces one more worry on the charts—a "death cross."
Technician Carter Worth says Apple and biotech look "married." He explains why they are the must-own names right now.
Get knock-your-socks-off tools, simple one-click orders, real-time paper trading to hone your skills, and 24/7 support from dedicated trading specialists. Trade commission-free for 60 days and get up to $600 cash.
Make sure you’re always keeping up with the market with up-to-the-minute news and breaking stories. Move on possible breakout stocks and options with potential opportunity. Plus, get in-depth analysis on futures and forex in one seamless, integrated experience. Join TD Ameritrade and trade commission-free for 60 days + get up to $600 cash.